Prevention by catatoxic steroids of lithocholic acid-induced biliary concrements in the rat.
D000818:Animals; D001647:Bile Acids and Salts / Q000494:pharmacology*; D001835:Body Weight; D003135:Common Bile Duct / Q000187:drug effects*; D005260:Female; D042882:Gallstones / Q000188:drug therapy*; D007565:Jaundice / Q000188:drug therapy; D008095:Lithocholic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008099:Liver / Q000187:drug effects*; D009570:Nitriles / Q000627:therapeutic use; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011422:Propionates / Q000627:therapeutic use; D051381:Rats; D013256:Steroids / Q000627:therapeutic use*; D013974:Thyroxine / Q000627:therapeutic use; D014221:Triamcinolone / Q000494:pharmacology; D014284:Triiodothyronine / Q000627:therapeutic use
D001647:Bile Acids and Salts; D009570:Nitriles; D011422:Propionates; D013256:Steroids; D014284:Triiodothyronine; D014221:Triamcinolone; D008095:Lithocholic Acid; D010672:Phenytoin; D011239:Prednisolone; D013974:Thyroxine; D010634:Phenobarbital